CD274 and neoplasm: Daniel et al. demonstrated that PD‐L1 expression on tumor‐associated macrophages or tumor cells was associated with improved survival in patients receiving ACT, while high myeloid content or low lymphoid content was associated with a higher risk of death in the non‐ACT cohort.52